University of Bath:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Bath - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9285
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Bath (UOB) is an educational institution that provides educational and research services. The institute provides under graduate and post graduate programs in the fields of science, engineering and design, humanities and social sciences, and management studies. It also conducts research in fields of health, business, environment, transport and technology, among others. UOB provides research areas such as healthcare technologies, aerospace, energy, nano research, biotechnology, drug discovery and development, design and manufacturing, among others. The institute also offers business services. It partners with research councils, government, industry, charities and international organizations for business, higher education and research, among others. UOB is headquartered Bath, the UK.

University of Bath – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Bath, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Bath, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Bath, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Bath, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Bath, Medical Devices Deals, 2012 to YTD 2018 9
University of Bath, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Bath, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Azellon Raises USD2 Million in Venture Financing 11
Partnerships 13
Sapience Therapeutics Enters into Research Agreement with University of Bath 13
Licensing Agreements 14
Orexigen Therapeutics Enters into Licensing Agreement with University of Bath 14
University of Bath – Key Competitors 15
University of Bath – Key Employees 16
University of Bath – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Jun 12, 2018: Potential treatment for drug addiction relapse revealed 18
May 11, 2018: Scientists screen molecules for potential as new prostate cancer drugs 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
University of Bath, Pharmaceuticals & Healthcare, Key Facts 2
University of Bath, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Bath, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Bath, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Bath, Deals By Therapy Area, 2012 to YTD 2018 8
University of Bath, Medical Devices Deals, 2012 to YTD 2018 9
University of Bath, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Azellon Raises USD2 Million in Venture Financing 11
Sapience Therapeutics Enters into Research Agreement with University of Bath 13
Orexigen Therapeutics Enters into Licensing Agreement with University of Bath 14
University of Bath, Key Competitors 15
University of Bath, Key Employees 16

List of Figures
University of Bath, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Bath, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Bath, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Bath, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Bath, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Bath, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Bath, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Bath, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Bath, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Bath:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Streamwide SA (ALSTW):企業の財務・戦略的SWOT分析
    Streamwide SA (ALSTW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務情報
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Micell Technologies Inc:製品パイプライン分析
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company offers product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to optim …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kaefer Isoliertechnik GmbH & Co KG:企業の戦略・SWOT・財務情報
    Kaefer Isoliertechnik GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Kaefer Isoliertechnik GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Terme Dobrna d.d.:企業の戦略・SWOT・財務情報
    Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Generex Biotechnology Corp (GNBT):企業の戦略的SWOT分析
    Generex Biotechnology Corp (GNBT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Eagle Bancorp Inc:企業の戦略・SWOT・財務分析
    Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務分析
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Suntory Holdings Ltd:戦略・SWOT・企業財務分析
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MYR Group Inc (MYRG):企業の財務・戦略的SWOT分析
    Summary MYR Group Inc (MYR Group) is an electrical contractor that provides specialty contracting services for industrial, commercial, and electrical infrastructure markets. The company operates substations, transmission lines, and distribution systems. It offers services such as distribution constr …
  • gategroup Holding AG:企業の戦略・SWOT・財務情報
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Black Knight Inc (BKI):企業の財務・戦略的SWOT分析
    Black Knight Inc (BKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Red Hill Iron Limited:企業の戦略・SWOT・財務分析
    Red Hill Iron Limited - Strategy, SWOT and Corporate Finance Report Summary Red Hill Iron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Whiting Petroleum Corp (WLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rocky Mountains region of the US. The company has oil and gas properties in Northern Rocky Mountains whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆